全文获取类型
收费全文 | 3938篇 |
免费 | 368篇 |
国内免费 | 1篇 |
出版年
2022年 | 40篇 |
2021年 | 89篇 |
2020年 | 46篇 |
2019年 | 59篇 |
2018年 | 73篇 |
2017年 | 47篇 |
2016年 | 102篇 |
2015年 | 188篇 |
2014年 | 200篇 |
2013年 | 248篇 |
2012年 | 241篇 |
2011年 | 265篇 |
2010年 | 157篇 |
2009年 | 125篇 |
2008年 | 193篇 |
2007年 | 200篇 |
2006年 | 186篇 |
2005年 | 188篇 |
2004年 | 166篇 |
2003年 | 138篇 |
2002年 | 139篇 |
2001年 | 63篇 |
2000年 | 55篇 |
1999年 | 55篇 |
1998年 | 48篇 |
1997年 | 32篇 |
1996年 | 32篇 |
1995年 | 29篇 |
1994年 | 26篇 |
1993年 | 32篇 |
1992年 | 51篇 |
1991年 | 39篇 |
1990年 | 29篇 |
1989年 | 37篇 |
1988年 | 36篇 |
1987年 | 23篇 |
1985年 | 27篇 |
1984年 | 28篇 |
1983年 | 28篇 |
1982年 | 33篇 |
1981年 | 25篇 |
1980年 | 34篇 |
1979年 | 24篇 |
1978年 | 26篇 |
1977年 | 21篇 |
1976年 | 20篇 |
1975年 | 18篇 |
1974年 | 23篇 |
1973年 | 21篇 |
1971年 | 26篇 |
排序方式: 共有4307条查询结果,搜索用时 15 毫秒
981.
Chang SY Hudon-Miller SE Yang SH Jung HJ Lee JM Farber E Subramanian T Andres DA Spielmann HP Hrycyna CA Young SG Fong LG 《Journal of lipid research》2012,53(6):1176-1182
Protein farnesyltransferase (FTase) inhibitors, generally called "FTIs," block the farnesylation of prelamin A, inhibiting the biogenesis of mature lamin A and leading to an accumulation of prelamin A within cells. A recent report found that a GGTI, an inhibitor of protein geranylgeranyltransferase-I (GGTase-I), caused an exaggerated accumulation of prelamin A in the presence of low amounts of an FTI. This finding was interpreted as indicating that prelamin A can be alternately prenylated by GGTase-I and that inhibiting both protein prenyltransferases leads to more prelamin A accumulation than blocking FTase alone. Here, we tested an alternative hypothesis-GGTIs are not specific for GGTase-I, and they lead to prelamin A accumulation by inhibiting ZMPSTE24 (a zinc metalloprotease that converts farnesyl-prelamin A to mature lamin A). In our studies, commonly used GGTIs caused prelamin A accumulation in human fibroblasts, but the prelamin A in GGTI-treated cells exhibited a more rapid electrophoretic mobility than prelamin A from FTI-treated cells. The latter finding suggested that the prelamin A in GGTI-treated cells might be farnesylated (which would be consistent with the notion that GGTIs inhibit ZMPSTE24). Indeed, metabolic labeling studies revealed that the prelamin A in GGTI-treated fibroblasts is farnesylated. Moreover, biochemical assays of ZMPSTE24 activity showed that ZMPSTE24 is potently inhibited by a GGTI. Our studies show that GGTIs inhibit ZMPSTE24, leading to an accumulation of farnesyl-prelamin A. Thus, caution is required when interpreting the effects of GGTIs on prelamin A processing. 相似文献
982.
Virginia M. Tanis Genesis M. Bacani Jonathan M. Blevitt Christa C. Chrovian Shelby Crawford Aimee De Leon Anne M. Fourie Laurent Gomez Cheryl A. Grice Krystal Herman Aaron M. Kearney Adrienne M. Landry-Bayle Alice Lee-Dutra Jay Nelson Jason P. Riley Alejandro Santillán John J.M. Wiener Xiaohua Xue Arlene L. Young 《Bioorganic & medicinal chemistry letters》2012,22(24):7504-7511
Previously, benzthiazole containing LTA4H inhibitors were discovered that were potent (1–3), but were associated with the potential for a hERG liability. Utilizing medicinal chemistry first principles (e.g., introducing rigidity, lowering c Log D) a new benzthiazole series was designed, congeners of 1–3, which led to compounds 7a, 7c, 12a–d which exhibited LTA4H IC50 = 3–6 nM and hERG Dofetilide Binding IC50 = 8.9–> >10 μM. 相似文献
983.
984.
985.
Miguel Muñoz Ana González-Ortega Marisa Rosso María José Robles-Frias Andres Carranza Manuel Vicente Salinas-Martín Rafael Coveñas 《Peptides》2012
The last decades have seen no significant progress in extending the survival of lung cancer patients and there is an urgent need to improve current therapies. The substance P (SP)/neurokinin-1 receptor (NK-1R) system plays an important role in the development of cancer: SP and NK-1R antagonists respectively induce cell proliferation and inhibition in human cancer cell lines. No study of the involvement of this system in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells has been carried out in depth. Here, we demonstrate the involvement of the SP/NK-1R system in human H-69 (SCLC) and COR-L23 (NSCLC) cell lines: (1) they express isoforms of the NK-1R and mRNA for the NK-1R; (2) they overexpress the tachykinin 1 gene; (3) the NK-1R is involved in their viability; (4) SP induces their proliferation; (5) NK-1R antagonists (Aprepitant (Emend), L-733,060, L-732,138) inhibit the growth of both cell lines in a concentration-dependent manner; (6) the specific antitumor action of these antagonists against such cells occurs through the NK-1R; and (7) lung cancer cell death is due to apoptosis. We also demonstrate the presence of NK-1Rs and SP in all the human SCLC and NSCLC samples studied. Our findings indicate that the NK-1R may be a promising new target in the treatment of lung cancer and that NK-1R antagonists could be new candidate antitumor drugs in the treatment of SCLC and NSCLC. 相似文献
986.
Endo A Futagawa-Endo Y Schumann P Pukall R Dicks LM 《Systematic and applied microbiology》2012,35(2):92-97
Five strains of bifidobacteria were isolated from faeces of a common marmoset (Callithrix jacchus) and a red-handed tamarin (Saguinus midas). The five isolates clustered inside the phylogenetic group of the genus Bifidobacterium but did not show high sequence similarities between the isolates and to known species in the genus by phylogenetic analysis based on 16S rRNA gene sequences. Sequence analyses of dnaJ1 and hsp60 also indicated their independent phylogenetic positions to each other in the Bifidobacterium cluster. DNA G+C contents of the species ranged from 57.3 to 66.3 mol%, which is within the values recorded for Bifidobacterium species. All isolates showed fructose-6-phosphate phosphoketolase activity. Based on the data provided, the five isolates represent five novel species, for which the names Bifidobacterium reuteri sp. nov. (type strain: AFB22-1(T) = JCM 17295(T) = DSM 23975(T)), Bifidobacterium callitrichos sp. nov. (type strain: AFB22-5(T) = JCM 17296(T) = DSM 23973(T)), Bifidobacterium saguini sp. nov. (type strain: AFB23-1(T) = JCM 17297(T) = DSM 23967(T)), Bifidobacterium stellenboschense sp. nov. (type strain: AFB23-3(T) = JCM 17298(T) = DSM 23968(T)) and Bifidobacterium biavatii sp. nov. (type strain: AFB23-4(T) = JCM 17299(T) = DSM 23969(T)) are proposed. 相似文献
987.
Isabel Mendizabal Oscar Lao Urko M. Marigorta Andreas Wollstein Leonor Gusmão Vladimir Ferak Mihai Ioana Albena Jordanova Radka Kaneva Anastasia Kouvatsi Vaidutis Kučinskas Halyna Makukh Andres Metspalu Mihai G. Netea Rosario de Pablo Horolma Pamjav Dragica Radojkovic Sarah J.H. Rolleston Jadranka Sertic Milan Macek Manfred Kayser 《Current biology : CB》2012,22(24):2342-2349
988.
Kershenbaum A Ilany A Blaustein L Geffen E 《Proceedings. Biological sciences / The Royal Society》2012,279(1740):2974-2981
Few mammalian species produce vocalizations that are as richly structured as bird songs, and this greatly restricts the capacity for information transfer. Syntactically complex mammalian vocalizations have been previously studied only in primates, cetaceans and bats. We provide evidence of complex syntactic vocalizations in a small social mammal: the rock hyrax (Procavia capensis: Hyracoidea). We adopted three algorithms, commonly used in genetic sequence analysis and information theory, to examine the order of syllables in hyrax calls. Syntactic dialects exist, and the syntax of hyrax calls is significantly different between different regions in Israel. Call syntax difference is positively correlated to geographical distance over short distances. No correlation is found over long distances, which may reflect limited dispersal movement. These findings indicate that rich syntactic structure is more common in the vocalizations of mammalian taxa than previously thought and suggest the possibility of vocal production learning in the hyrax. 相似文献
989.
Jahic M Knoblechner J Charoenrat T Enfors SO Veide A 《Biotechnology and bioengineering》2006,93(6):1040-1049
For improved interfacing of the Pichia pastoris fed-batch cultivation process with expanded bed adsorption (EBA) technique, a modified cultivation technique was developed. The modification included the reduction of the medium salt concentration, which was then kept constant by regulating the medium conductivity at low value (about 8 mS/cm) by salt feeding. Before loading, the low conductivity culture broth was diluted only to reduce viscosity, caused by high cell density. The concept was applied to a one-step recovery and purification procedure for a fusion protein composed of a cellulose-binding module (CBM) from Neocallimastix patriciarum cellulase 6A fused to lipase B from Candida antarctica (CALB). The modified cultivation technique resulted in lower cell death and consequently lower concentration of proteases and other contaminating proteins in the culture broth. Flow cytometry analysis showed 1% dead (propidium-stained) cells compared to 3.5% in the reference process. During the whole process of cultivation and recovery, no proteolysis was detected and in the end of the cultivation, the product constituted 87% of the total supernatant protein. The lipase activity in the culture supernatant increased at an almost constant rate up to a value corresponding to 2.2 g/L of CBM-CALB. In the EBA process, no cell-adsorbent interaction was detected but the cell density had to be reduced by a two-times dilution to keep a proper bed expansion. At flow velocity of 400 cm/h, the breakthrough capacity was 12.4 g/L, the product yield 98%, the concentration factor 3.6 times, the purity about 90%, and the productivity 2.1 g/L x h. 相似文献
990.